Redhill Biopharma Ltd. (RDHL)
RDHL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5150
-3.45% on the day
Market cap
$3.1M
Nano cap
Revenue · 2024
$8.0M
No prior year to compare
Net income · 2024
-$8.3M
-102.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/1553846/000155837025004648/0001558370-25-004648-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), period ending 2024-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | RDHL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0001553846 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $8.0M |
| Net income | -$8.3M |
| Operating income | Not in SEC XBRL data |
| Net margin | -102.8% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-10-13 |
| Latest annual report | 20-F | 2026-04-27 |
| Latest quarterly / interim | 6-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
| CMND | Clearmind Medicine Inc. Common Shares | $6.23 | -4.74% | $3.2M |
| SXTP | 60 Degrees Pharmaceuticals Inc. | $0.9000 | -1.70% | $3.2M |
| XRTX | XORTX Therapeutics Inc. Common Shares | $1.68 | -2.33% | $3.1M |
| CAPS | Capstone Holding Corp. | $0.1242 | -6.83% | $3.3M |
| EOCN | Eocene Ltd. | $3.17 | -1.71% | $3.3M |
| DCOY | Decoy Therapeutics Inc. | $1.24 | -13.29% | $3.0M |
| ONCO | Onconetix Inc. | $0.5550 | -6.00% | $2.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier